Division Title

Institutional Biosafety Committee

Institutional Biosafety Committee

The NIH Institutional Biosafety Committee (IBC) provides recommendations to the Director of the NIH or his designee, in matters pertaining to the control of hazards associated with the intramural use of microbiological agents, their vectors, and recombinant DNA. The committee serves as an advisory body to the Division of Occupational Health and Safety (DOHS), Office of Research Services (ORS).

Recombinant DNA and Pathogen Registration submissions are submitted electronically through the Electronic Registration System (ERS). Please check the  NIH: IBC Meeting and Deadline Dates  for   Bethesda campus and RML IBC Meeting and Deadline Dates for Rocky Mountain Lab (RML) campus .  Membership roster for RML IBC Committee :RML IBC Membership.

Read more from the external linksCharter for the NIH Institutional Biosafety Committee. 

Membership Roster



Committee Role

Harry L. Malech

Chairperson, Clinican

Richard G. Baumann

Biological Safety Officer, Voting Contact

​Robert Craigie

Committee Member, Clinician

​Alicia Alexion

Local Non-Affiliated

Jocelyn Dunford-Weissman

​Senior Research Associate

Avijeet( and Ishveen) Chopra

​Scientific Technical Writers

Althea Treacy

Associate Biological Safety Officer, QPSO Lead

Lauren Reoma

Committee Member, Clinician

Jeanne Billioux

Committee Member, Clinician

​Michael Kujawa

​Commmittee Member, IBC Coordinator

​Stephen L. Denny

​Animal Expert, Animal Program Director

Clevetta Drew

Local Non-Affiliated

Stephanie M. Goff

Committee Member

​Steve S. Whitehead

​Committee Member, Virologist